Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600117028) titled 'Clinical study on the exploration of effective dosage,safety and comfort of Anricafen for moderate pain' on Jan. 19.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: the Second Affiliated Hospital of Soochow University
Condition:
postoperative analgesia
Intervention:
Control Group:Morphine
Phase One:For Anrikefon, the sequential method is used for drug administration, with the dosage for the next subject adjusted based on the analgesic response of the previous subject.
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-01-19
Target Sample Size: Control ...